12. SOME EPIDEMIOLOGICAL AND HISTOPATHOLOGICAL CHARACTERISTICS OF LUNG CANCER IN HANOI IN 2015-2019
Main Article Content
Abstract
Objective: The study aimed to describe some epidemiological and histopathological characteristics
of lung cancer in Hanoi from 2015 to 2019. Methods: Retrospective study. Data were recorded from
30 hospitals in Hanoi according to the principles of organization of population cancer registration
recommended by the International Agency for Research on Cancer (IARC) from January 1, 2015 to
December 31, 2019. The total number of disease stages (n=966) and histopathology (n=1351) were
recorded.
Results: The disease was mainly detected at the late stage (71.2% were stage IV and 20.3% were
stage III). The rate of stage IV lung cancer was highest in both urban and suburban areas. However,
the urban area (74.9 %) was higher than the suburban area (69.0%). From stage 0 to III, the suburbs
were higher than the urban area. According to histopathology results, adenocarcinoma had the highest
rate (60.5%) and was higher in females than in males (79.4% vs. 53.7%). Small and squamous cell
lung cancer was more common among males (11.6% and 14.5%) than in females (1.1% and 5.4%).
Conclusions: Lung cancer was found late, so the mortality rate was high. Therefore, it was necessary
to strengthen screening and early detection of lung cancer in people at risk to help choose appropriate
interventions to inhibit cellular activities and improve the patient’s quality of life.
Article Details
Keywords
Histopathology, epidemiology, lung cancer, Hanoi.
References
Cancer Statistics 2020: GLOBOCAN Estimates
of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries”, CA Cancer J Clin.
71(3), pp. 209-249, 2021.
[2] de Groot PM, Wu CC, Carter BW et al., “The
epidemiology of lung cancer”, Transl Lung
Cancer Res. 7(3), pp. 220-233, 2018.
[3] Molina JR, Yang P, Cassivi SD, Schild SE et al.,
“Non-small cell lung cancer: epidemiology, risk
factors, treatment, and survivorship”, Mayo Clin
Proc. 83(5), pp. 584-594, 2008.
[4] Barta JA, Powell CA, Wisnivesky JP, “ Global
Epidemiology of Lung Cancer”, Ann Glob
Health. 85(1), p. 8, 2019.
[5] Bộ môn Dịch tễ học- Đại học Y Hà Nội, Giáo
trình dịch tễ học một số bệnh phổ biến.Hà Nội:
NXB Y học, 2019.
[6] World Health Organization, International
classification of diseases for oncology
(ICD-O),3rded.,1strevision. World Health
Organization. https://apps.who.int/iris/
handle/10665/96612, 2013
[7] Lê Tuấn Anh, Nguyễn Ngọc Bảo Hoàng, “Đặc
điểm lâm sàng và điều trị của 1158 bệnh nhân
ung thư phổi tại Trung tâm ung bướu Chợ Rẫy”,
Tạp chí Y học thực hành. 878(8), pp. 20-22, 2013.
[8] Tran HTT, Nguyen S, Nguyen KK et al., “Lung
Cancer in Vietnam”, Thoractic Oncology. 16(9),
p. 1443, 2021.
[9] Sobue T, Suzuki T, Horai T et al., “Relationship
between cigarette smoking and histologic type
of lung cancer, with special reference to sex
difference”, Jpn J Clin Oncol. 18(1), pp. 3-13,
1988.
[10] Rusmaully J, Tvardik N, Martin D et al., “Risk of
lung cancer among women in relation to lifetime
history of tobacco smoking: a population-based
case-control study in France (the WELCA
study)”, BMC Cancer. 21(1), p. 711, 2021.
[11] Kurahashi N, Inoue M, Liu Y et al., “ Passive
smoking and lung cancer in Japanese nonsmoking
women: a prospective study”, Int J
Cancer. 122(3), pp. 653-657, 2008.